 HLA Antigens
"HLA Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.
| Descriptor ID |
D006680
|
| MeSH Number(s) |
D23.050.301.500.450 D23.050.705.552.450
|
| Concept/Terms |
HLA Antigens- HLA Antigens
- Antigens, HLA
- HL-A Antigens
- Antigens, HL-A
- HL A Antigens
- Human Leukocyte Antigens
- Antigens, Human Leukocyte
- Leukocyte Antigens, Human
- Leukocyte Antigens
- Antigens, Leukocyte
|
Below are MeSH descriptors whose meaning is more general than "HLA Antigens".
Below are MeSH descriptors whose meaning is more specific than "HLA Antigens".
This graph shows the total number of publications written about "HLA Antigens" by people in UAMS Profiles by year, and whether "HLA Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2025 | 1 | 1 | 2 | | 2024 | 1 | 0 | 1 | | 2023 | 0 | 3 | 3 | | 2021 | 1 | 1 | 2 | | 2019 | 1 | 0 | 1 | | 2017 | 1 | 1 | 2 | | 2015 | 1 | 0 | 1 | | 2014 | 2 | 0 | 2 | | 2013 | 2 | 0 | 2 | | 2012 | 1 | 0 | 1 | | 2011 | 0 | 1 | 1 | | 2010 | 1 | 0 | 1 | | 2008 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2006 | 1 | 1 | 2 | | 2005 | 1 | 0 | 1 | | 2004 | 1 | 2 | 3 | | 2003 | 0 | 3 | 3 | | 2002 | 2 | 1 | 3 | | 1990 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "HLA Antigens" by people in Profiles over the past ten years.
-
L?z?r-Moln?r E, Truax CM, Eiting MM, Jain D, Hurst D, Zukauckas K, Pearce A, Bergam S, Gardner S, Clayton F, Florido R, Stehlik J, Shah KS. First use of imlifidase desensitization in a highly sensitized heart and liver transplant candidate: A case report. Hum Immunol. 2025 Sep; 86(5):111584.
-
Sullivan HC, Jaramillo A, Gaitonde S, Murphey C, Pandey S, Liu C, Jindra P, Hidalgo LG, Weimer ET, Alquist CR, Morris GP, Bray RA. Virtual crossmatching: Principles, practices, and the path forward-An American Society for Histocompatibility and Immunogenetics/College of American Pathologists collaborative. Am J Transplant. 2025 Oct; 25(10):2048-2056.
-
Kongtim P, Vittayawacharin P, Zou J, Srour S, Shaffer B, Shapiro RM, Varma A, McGuirk J, Dholaria BR, McCurdy SR, DeZern AE, Bejanyan N, Bashey A, Furst S, Castagna L, Mariotti J, Ruggeri A, Bailen R, Teshima T, Xiao-Jun H, Bonfim C, Aung F, Cao K, Carpenter PA, Hamadani M, Askar M, Fernandez-Vina M, Girnita A, Ciurea SO. ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies. Transplant Cell Ther. 2024 12; 30(12):1139-1154.
-
Tsai YY, Qu C, Bonner JD, Sanz-Pamplona R, Lindsey SS, Melas M, McDonnell KJ, Idos GE, Walker CP, Tsang KK, Da Silva DM, Moratalla-Navarro F, Maoz A, Rennert HS, Kast WM, Greenson JK, Moreno V, Rennert G, Gruber SB, Schmit SL. Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer. Front Immunol. 2023; 14:1268117.
-
Morehead LC, Koss B, Fil D, Heflin B, Garg S, Wallis KF, Tackett AJ, Miousse IR. Resveratrol induces major histocompatibility complex class I antigen presentation in a STING-dependent and independent manner in melanoma. Mol Immunol. 2023 11; 163:188-195.
-
Zongo SV, Djigma FW, Yonli AT, Sorgho PA, Nagalo BM, Traore L, Somda D, Amegnona LJ, Languie E, Some CCB, Sia LMJ, Sourabie IB, Sombie RA, Serme AK, Obiri-Yeboah D, Simpore J. Association of DRB1*11 and DRB1*12 alleles of the HLA system with the evolution of the Hepatitis B virus infection in Burkina Faso. Mol Biol Rep. 2023 Jun; 50(6):5039-5047.
-
Vogel AD, Kwon JH, Mitta A, Sherard C, Brockbank KGM, Rajab TK. Immunogenicity of Homologous Heart Valves: Mechanisms and Future Considerations. Cardiol Rev. 2024 Sep-Oct 01; 32(5):385-391.
-
Greaney AJ, Starr TN, Barnes CO, Weisblum Y, Schmidt F, Caskey M, Gaebler C, Cho A, Agudelo M, Finkin S, Wang Z, Poston D, Muecksch F, Hatziioannou T, Bieniasz PD, Robbiani DF, Nussenzweig MC, Bjorkman PJ, Bloom JD. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nat Commun. 2021 07 07; 12(1):4196.
-
Karafin MS, Schumacher C, Zhang J, Simpson P, Johnson ST, Pierce KL. Human leukocyte antigen (HLA)-incompatible mean fluorescence intensity-selected platelet products have corrected count increments similar to HLA antigen-matched platelets. Transfusion. 2021 08; 61(8):2307-2316.
-
Pandey S, Harville TO. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA). Ann Clin Lab Sci. 2019 Jan; 49(1):50-56.
-
Liu J, Bian Z, Wang X, Xu LP, Fu Q, Wang C, Chang YJ, Wang Y, Zhang XH, Jiang Z, Huang XJ. Inverse correlation of Vd2+ T-cell recovery with EBV reactivation after haematopoietic stem cell transplantation. Br J Haematol. 2018 01; 180(2):276-285.
-
Dias AL, Hashmi S, Hogan W, Baig N, Wakefield L, Kreuter J, Gandhi MJ. The 'HLA conundrum in bone marrow transplantation': correct interpretation of anti-HLA antibodies in haploidentical donor selection. Bone Marrow Transplant. 2017 06; 52(6):902-904.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|